Cargando…
Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History
Immunization against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has significantly limited the spread of coronavirus disease 2019 (COVID-19) and reduced the associated complications, especially mortality. To prolong immunity, an immune booster was implemented. We evaluated the role...
Autores principales: | Nazaruk, Paulina, Tkaczyk, Ignacy, Monticolo, Marta, Jędrzejczak, Anna Maria, Krata, Natalia, Pączek, Leszek, Foroncewicz, Bartosz, Mucha, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458920/ https://www.ncbi.nlm.nih.gov/pubmed/37631947 http://dx.doi.org/10.3390/vaccines11081380 |
Ejemplares similares
-
Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only?
por: Nazaruk, Paulina, et al.
Publicado: (2021) -
The Different Patterns of Over-the-Counter Nonsteroidal Anti-Inflammatory Drugs or Analgesics Use in Patients with Chronic Kidney Disease and the General Population
por: Mulka-Gierek, Maria, et al.
Publicado: (2022) -
Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis
por: Krata, Natalia, et al.
Publicado: (2021) -
Osteopontin—A Potential Biomarker for IgA Nephropathy: Machine Learning Application
por: Moszczuk, Barbara, et al.
Publicado: (2022) -
Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)